These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1678734)
1. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Rilke F; Colnaghi MI; Cascinelli N; Andreola S; Baldini MT; Bufalino R; Della Porta G; Ménard S; Pierotti MA; Testori A Int J Cancer; 1991 Aug; 49(1):44-9. PubMed ID: 1678734 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the quantitative measurement of the oncoprotein p185(Her-2/neu) in a group of patients with breast cancer and positive node involvement. Bohn U; Aguiar J; Bilbao C; Murias A; Vega V; Chirino R; Díaz-Chico N; Díaz-Chico JC Int J Cancer; 2002 Oct; 101(6):539-44. PubMed ID: 12237894 [TBL] [Abstract][Full Text] [Related]
3. c-erbB2 expression in correlation to other biological parameters of breast cancer. Marx D; Schauer A; Reiche C; May A; Ummenhofer L; Reles A; Rauschecker H; Sauer R; Schumacher M J Cancer Res Clin Oncol; 1990; 116(1):15-20. PubMed ID: 1968902 [TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients. Riou G; Mathieu MC; Barrois M; Le Bihan ML; Ahomadegbe JC; Bénard J; Lê MG Int J Cancer; 2001 Jul; 95(4):266-70. PubMed ID: 11400121 [TBL] [Abstract][Full Text] [Related]
5. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. Toikkanen S; Helin H; Isola J; Joensuu H J Clin Oncol; 1992 Jul; 10(7):1044-8. PubMed ID: 1351537 [TBL] [Abstract][Full Text] [Related]
8. Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma. Bermont L; Algros MP; Baron MH; Adessi GL Breast Cancer Res Treat; 2000 Sep; 63(2):163-9. PubMed ID: 11097092 [TBL] [Abstract][Full Text] [Related]
9. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. Têtu B; Brisson J Cancer; 1994 May; 73(9):2359-65. PubMed ID: 7909490 [TBL] [Abstract][Full Text] [Related]
12. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Christianson TA; Doherty JK; Lin YJ; Ramsey EE; Holmes R; Keenan EJ; Clinton GM Cancer Res; 1998 Nov; 58(22):5123-9. PubMed ID: 9823322 [TBL] [Abstract][Full Text] [Related]
13. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive]. Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314 [TBL] [Abstract][Full Text] [Related]
14. HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D. Korkolis D; Ardavanis A; Yotis J; Kyroudi A; Gorgoulis V; Kittas C Anticancer Res; 2001; 21(3C):2207-12. PubMed ID: 11501848 [TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Dati C; Muraca R; Tazartes O; Antoniotti S; Perroteau I; Giai M; Cortese P; Sismondi P; Saglio G; De Bortoli M Int J Cancer; 1991 Apr; 47(6):833-8. PubMed ID: 1672666 [TBL] [Abstract][Full Text] [Related]
16. [Overexpression of c-erbB-2 gene product is associated with poor prognosis factors in breast carcinoma]. Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):349-53. PubMed ID: 14755939 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. Seshadri R; Firgaira FA; Horsfall DJ; McCaul K; Setlur V; Kitchen P J Clin Oncol; 1993 Oct; 11(10):1936-42. PubMed ID: 8105035 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors. Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451 [TBL] [Abstract][Full Text] [Related]
19. Her-2/neu oncogene expression in Puerto Rican females with breast cancer. Peredo R; Sastre G; Serrano J; Hunter Mellado R Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652 [TBL] [Abstract][Full Text] [Related]
20. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]